4-Methylbenzylamine → 4-amino-5-cyano-6-ethoxy-N-(4-methylbenzyl)pyridine-2-carboxamide

HRID 1364541Notes

Reaction equation

HRID 1364541 reaction equation
[NH2:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([O:10][CH2:11][CH3:12])[N:5]=[C:4]([C:13]([OH:15])=O)[CH:3]=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.[B-](F)(F)(F)F.[CH3:38][C:39]1[CH:46]=[CH:45][C:42]([CH2:43][NH2:44])=[CH:41][CH:40]=1>CC(N(C)C)=O>[NH2:1][C:2]1[C:7]([C:8]#[N:9])=[C:6]([O:10][CH2:11][CH3:12])[N:5]=[C:4]([C:13]([NH:44][CH2:43][C:42]2[CH:45]=[CH:46][C:39]([CH3:38])=[CH:40][CH:41]=2)=[O:15])[CH:3]=1

Participants

5

Procedure

In a 20 mL scintillation vial, 4-amino-5-cyano-6-ethoxy-pyridine-2-carboxylic acid (19 mg, 0.09 mmol) was dissolved in DMA (0.7 mL). Then TBTU (30 mg, 0.09 mmol) dissolved in DMA (0.7 mL) was added, followed by the addition of 4-methylbenzylamine (12 mg, 0.11 mmol, 1.2 eq.) in DMA (0.6 mL). Then TEA (9.37 mg, 0.09 mmol) dissolved in DMA (0.7 mL) was added. The reaction mixture was shaken at room temperature for 24 hours. The crude mixture was purified using reverse phase HPLC (TFA). 1H NMR (500 MHz, DMSO-D6/D2O) 1.23-1.36 (m, 3H) 2.20-2.34 (m, 3H) 4.37-4.55 (m, 4H) 7.04-7.22 (m, 4H) 8.97-9.10 (m, 1H). MS (ESI) positive ion 311 (M+H)+; negative ion 309 (M−H)−.

Workup

  1. additionwas added
  2. additionwas added
  3. customThe crude mixture was purified

Sources & evidence

ORD record
ord-224d4256a47b47edb5e67587ce9d8f44
Source dataset
uspto-grants-2011_02
Patent number
US07888374B2

Reaction notes

Loading…